LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Selumetinib | 10.0 | uM | LJP6 | 72 | hr | 513 | 900 | 10401 | 0.0866 | 0.0391 |
MCF 10A | Sirolimus | 10.0 | uM | LJP6 | 72 | hr | 513 | 9940 | 10401 | 0.9557 | 0.9534 |
MCF 10A | Sorafenib | 10.0 | uM | LJP6 | 72 | hr | 513 | 5955 | 10401 | 0.5726 | 0.5504 |
MCF 10A | SU11274 | 10.0 | uM | LJP5 | 72 | hr | 513 | 2602 | 10401 | 0.2502 | 0.2112 |
MCF 10A | Fedratinib | 10.0 | uM | LJP5 | 72 | hr | 513 | 570 | 10401 | 0.0549 | 0.0058 |
MCF 10A | TGX221 | 10.0 | uM | LJP5 | 72 | hr | 513 | 7674 | 10401 | 0.7378 | 0.7242 |
MCF 10A | Torin1 | 10.0 | uM | LJP6 | 72 | hr | 513 | 863 | 10401 | 0.0830 | 0.0354 |
MCF 10A | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 513 | 484 | 10401 | 0.0465 | -0.0030 |
MCF 10A | Tozasertib | 10.0 | uM | LJP5 | 72 | hr | 513 | 824 | 10401 | 0.0792 | 0.0314 |
MCF 10A | Trametinib | 10.0 | uM | LJP5 | 72 | hr | 513 | 1020 | 10401 | 0.0981 | 0.0513 |
MCF 10A | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 513 | 385 | 10401 | 0.0371 | -0.0129 |
MCF 10A | Vemurafenib | 10.0 | uM | LJP5 | 72 | hr | 513 | 1903 | 10401 | 0.1830 | 0.1406 |
MCF 10A | Withaferin A | 10.0 | uM | LJP5 | 72 | hr | 513 | 321 | 10401 | 0.0309 | -0.0194 |
MCF 10A | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 513 | 325 | 10401 | 0.0312 | -0.0191 |
MCF 10A | WYE-125132 | 10.0 | uM | LJP6 | 72 | hr | 513 | 882 | 10401 | 0.0848 | 0.0373 |
MCF 10A | WZ3105 | 10.0 | uM | LJP5 | 72 | hr | 513 | 525 | 10401 | 0.0505 | 0.0012 |
MCF 10A | XMD11-50 | 10.0 | uM | LJP6 | 72 | hr | 513 | 931 | 10401 | 0.0895 | 0.0423 |
MCF 10A | Y39983 | 10.0 | uM | LJP6 | 72 | hr | 513 | 1133 | 10401 | 0.1090 | 0.0627 |
MCF 10A | YM 201636 | 10.0 | uM | LJP5 | 72 | hr | 513 | 1389 | 10401 | 0.1336 | 0.0886 |
MCF 10A | ZSTK474 | 10.0 | uM | LJP6 | 72 | hr | 513 | 1292 | 10401 | 0.1242 | 0.0787 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2830 | 4156 | 0.6811 | 0.5462 |
MCF7 | Sigma A6730 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3330 | 4156 | 0.8014 | 0.7174 |
MCF7 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1126 | 4156 | 0.2709 | -0.0375 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3560 | 4156 | 0.8567 | 0.7961 |
MCF7 | AZD 5438 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3569 | 4156 | 0.8589 | 0.7992 |